Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Xylo Technologies Ltd.

Xylo Technologies Ltd. (MDGS) Stock Overview

Explore Xylo Technologies Ltd.’s financial performance, market position, analyst ratings, and future outlook.

MDGS●NASDAQ
HealthcareMedical - Devices
$2.36
$0.22(10.28%)
U.S. Market opens in 3h 6m

Xylo Technologies Ltd. (MDGS)

Meyka AI Score

Z

Key Financials

Market Cap178.9M
P/E Ratio-0.01
EPS (TTM)$-8.70
ROE-0.51%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

MDGS Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Xylo Technologies Ltd. (NASDAQ: MDGS) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Xylo Technologies Ltd.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of MDGS on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Xylo Technologies Ltd.'s NASDAQ-traded stock include a P/E ratio of -0.01 and a market capitalization of 178.9M. Combined with our AI analysis, these give both institutional and retail investors a clear view of MDGS on the NASDAQ.

Price Performance (NASDAQ: MDGS)

1-Day Change
N/A
5-Day Change
28.96%
1-Month Change
N/A
3-Month Change
-20.54%
6-Month Change
-20.00%
Year-to-Date (YTD) Change
-28.05%
1-Year Change
-57.63%
3-Year Change
-90.69%
5-Year Change
-94.36%
All-Time (Max) Change
-99.91%

Contact Information

https://www.medigus.com
972 73 370 4691
10 Hanechoshet, Tel Aviv, NaN, 6971072

Company Facts

380 Employees
IPO DateAug 5, 2015
CountryIL

Frequently Asked Questions